11th Cir. Appeals in Zantac MDL Dismissed for Lack of Final Judgments
November 8, 2022
DOCUMENTS
- Opinion
ATLANTA — A federal appellate panel has dismissed appeals filed by two individuals who allege their cancer was caused by their ingestion of contaminated Zantac (ranitidine), ruling that appellate jurisdiction is lacking because there was no final judgment issued by the MDL court that disposed of their claims.
In a Nov. 7 opinion, the 11th Circuit U.S. Court of Appeals explained that while it is possible that the claims remaining in the plaintiffs’ amended short form complaints, once paired with a pending master complaint, have little chance of surviving given the MDL court’s rulings, there is no final ruling putting …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach
HarrisMartin's New Jersey Asbestos Litigation Conference
February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick